Datamonitor's MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in the Healthcare industry.
Content
in this month's MarketWatch...
Pharmaceutical Company round-up
Cancer Update
News round-up
Opinion: Genentech: US approval for Avastin in breast cancer on thehorizon
Opinion: Bayer Schering: Nexavar suffers setback in lung cancer
Opinion: GSK: Tykerb to challenge Herceptin in breast cancer
Cardiovascular Update
News round-up
Central Nervous System Update
News round-up
Opinion: Kyowa Hakko: non-approvable letter for Parkininson's treatment
Opinion: Vernalis: revised R&D focus after Frova decision hits home
Idi Update
News round-up
Opinion: New Drug Applications: FDA increases focus on dataintegrity
Opinion: Daiichi: setback for anemia therapy
Infectious Diseases Update
News round-up
Opinion: Biocontrol Ltd: novel approach for treatment ofPseudomonas
Opinion: GlaxoSmithKline: cutting the cost of HIV drugs
Opinion: Tibotec: safety warning highlights limitation of proteaseinhibitors
Industry Update
Opinion: Pfizer: CEO says no mega deals are on the cards
Feature Analysis: Alcoholism drug market: shift in diseaseperception required for long-term growth
Feature Analysis: Google is well positioned to enter the personalhealth record market
Feature Analysis: Big Pharma rushing for foothold in emergingmarkets despite challenges